Drug
Etanercept
Etanercept: highest development phase Post-Market, developed by Amgen, Coherus BioSciences. 3 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Amgen, Coherus BioSciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| Etanercept NCT01543204 | Post-Market | Psoriasis |
| Etanercept NCT02115750 | Phase 3 | Rheumatoid Arthritis |
| Etanercept NCT00585650 | Phase 1/2 | Psoriasis |
Latest
No recent events.
Follow Etanercept on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.